Dr Allison Jilbert

Hepatitis B virus is responsible for 1.2 million deaths a year, including 320,000 deaths due to primary liver cancer. Dr Allison Jilbert of the IMVS, an affiliate researcher at the University of Adelaide, has always wanted to know why.

How does Hep B alter liver cells? Why does it happen over time? Why is there a high risk of liver cancer after a Hep B infection?

Dr Allison Jilbert and 350 million people worldwide are desperate for an answer. Armed with a long-held curiosity about the way viruses mutate and hijack cells as a host, Dr Jilbert and her team have Hep B under the microscope. “Our team is in a unique position to break through this baffling question.

Close collaboration between the IMVS, the Royal Adelaide Hospital and the University of Adelaide gives our group the best chance for success.”

Already the talented team has patented a therapy for the treatment of this disease that often infects the innocent.

Dr Jilbert believes team work will win out. “The University of Adelaide is at the forefront of research in this vital field, and I believe collaboration is the key to our success.”

Download Display Advertisement (pdf 140kB)